James Franklin exposed? Big questions after former doctor gets 5.25m!

Mountaineer Paul-

A recent courtroom drama has brought to light a contentious chapter in Penn State athletics, centered around allegations of interference and manipulation by football head coach James Franklin. Dr. Scott Lynch, a former orthopedic consultant and director of medicine for Penn State athletics, emerged as a central figure in this saga, ultimately awarded $5.25 million in damages in a lawsuit against Penn State Health. The case not only sheds light on Franklin’s actions but also raises concerns about the delicate balance between sports and medical decisions.

Lynch’s testimony during the trial painted a picture of strained relations between himself and Franklin, alleging that his termination was a result of resisting the coach’s attempts to influence medical treatment and return-to-play decisions. Another doctor, Dr. Pete Seidenberg, added weight to these claims, stating that he felt pressured by Franklin and then-athletic director Sandy Barbour to medically disqualify a player who had attempted suicide in order to free up a scholarship.

“The punishment for missing treatment was severe,” Lynch recounted during his testimony, highlighting Franklin’s decision to consider players who missed medical appointments as “full-go” at practices. Lynch’s suggestion of alternative disciplinary measures, such as having players clean the team’s locker rooms, was met with resistance from Franklin.

Moreover, Lynch testified about an incident where Franklin instructed him not to use specific medical terminology when discussing injuries with players. “When Coach Franklin didn’t like our decisions, he would sometimes call us in the office so he could put us in an intimidating environment to try to get us to change our minds,” Lynch said, illustrating the coach’s apparent disregard for medical expertise.

Lynch also detailed Franklin’s alleged frustration with medical procedures interfering with marketing agreements, noting that Franklin would become “angry” when trainers needed to put more tape on players’ ankles, as it often covered the Nike logo on Penn State’s team shoes. This aspect of Franklin’s behavior highlights concerns beyond player welfare, suggesting a prioritization of commercial interests over medical considerations.

Following Lynch’s termination, he engaged in discussions with Penn State Athletics integrity officer Robert Boland, expressing concerns about Franklin’s influence over medical decisions. Lynch described Franklin’s actions as attempts to “manipulate” medical outcomes to suit his agenda, a sentiment echoed by many medical professionals who feel pressured by coaches or administrators.

The verdict in Lynch’s favor underscores the seriousness of these allegations and their potential impact on player welfare. While Penn State Health has expressed disappointment with the decision and may consider an appeal, the case serves as a reminder of the need to prioritize the health and well-being of student-athletes above all else.

Franklin’s role in this controversy raises questions about the boundaries between sports and medical expertise within collegiate athletics. As the dust settles on this legal battle, it remains to be seen whether this case will prompt a reassessment of the power dynamics at play in the world of college sports. One thing, however, is clear: the spotlight on James Franklin and his actions has illuminated a larger conversation about ethics and accountability in athletics.